CVS Health Corporation $CVS Stake Boosted by Perigon Wealth Management LLC

Perigon Wealth Management LLC increased its stake in CVS Health Corporation (NYSE:CVS) by 126.0% during the 3rd quarter, HoldingsChannel reports. The firm owned 33,853 shares of the pharmacy operator’s stock after acquiring an additional 18,872 shares during the period. Perigon Wealth Management LLC’s holdings in CVS Health were worth $2,552,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently added to or reduced their stakes in CVS. Thompson Investment Management Inc. lifted its stake in CVS Health by 1.8% in the third quarter. Thompson Investment Management Inc. now owns 127,669 shares of the pharmacy operator’s stock valued at $9,625,000 after buying an additional 2,297 shares during the last quarter. Mayflower Financial Advisors LLC lifted its position in CVS Health by 9.4% in the 3rd quarter. Mayflower Financial Advisors LLC now owns 9,331 shares of the pharmacy operator’s stock valued at $703,000 after purchasing an additional 801 shares during the last quarter. FSM Wealth Advisors LLC boosted its stake in CVS Health by 2.9% during the 3rd quarter. FSM Wealth Advisors LLC now owns 10,203 shares of the pharmacy operator’s stock valued at $769,000 after purchasing an additional 289 shares during the period. Apella Capital LLC increased its stake in shares of CVS Health by 25.8% in the third quarter. Apella Capital LLC now owns 4,976 shares of the pharmacy operator’s stock valued at $405,000 after purchasing an additional 1,019 shares during the period. Finally, Persium Advisors LLC raised its holdings in shares of CVS Health by 6.2% during the third quarter. Persium Advisors LLC now owns 9,571 shares of the pharmacy operator’s stock valued at $722,000 after buying an additional 561 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several analysts recently commented on the company. Jefferies Financial Group raised their target price on CVS Health from $92.00 to $98.00 in a research report on Thursday, October 30th. Truist Financial set a $100.00 price target on CVS Health in a report on Wednesday, December 10th. Sanford C. Bernstein upped their price objective on shares of CVS Health from $86.00 to $87.00 and gave the stock a “market perform” rating in a report on Friday, December 12th. Raymond James Financial raised their target price on shares of CVS Health from $75.00 to $90.00 in a research note on Friday, October 31st. Finally, Leerink Partners upped their price target on shares of CVS Health from $86.00 to $95.00 and gave the stock an “outperform” rating in a research note on Thursday, October 16th. Two analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $94.67.

CVS Health Stock Performance

Shares of CVS opened at $79.96 on Tuesday. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.83 and a quick ratio of 0.63. The firm’s 50 day moving average is $78.86 and its 200-day moving average is $73.11. CVS Health Corporation has a 12-month low of $43.65 and a 12-month high of $85.15. The stock has a market capitalization of $101.50 billion, a P/E ratio of 210.41, a P/E/G ratio of 0.79 and a beta of 0.48.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, topping analysts’ consensus estimates of $1.36 by $0.24. The firm had revenue of $102.87 billion during the quarter, compared to analysts’ expectations of $98.85 billion. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The firm’s revenue for the quarter was up 7.8% compared to the same quarter last year. During the same period last year, the firm posted $1.09 earnings per share. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Equities research analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.